Artificial Intelligence framework with traditional computer vision and deep learning approaches for optimal automatic segmentation of left ventricle with scar

Artificial Intelligence in Heart Failure: Friend or Foe?

In recent times, there have been notable changes in cardiovascular medicine, propelled by the swift advancements in artificial intelligence (AI). The present work provides an overview of the current applications and challenges of AI in the field of heart failure. It emphasizes the "garbage in, garbage out" issue, where AI systems can produce inaccurate results with skewed data. The discussion covers issues in heart failure diagnostic algorithms, particularly discrepancies between existing models. Concerns about the reliance on the left ventricular ejection fraction (LVEF) for classification and treatment are highlighted, showcasing differences in current scientific perceptions. This review also delves into challenges in implementing AI, including variable considerations and biases in training data. It underscores the limitations of current AI models in real-world scenarios and the difficulty in interpreting their predictions, contributing to limited physician trust in AI-based models. The overarching suggestion is that AI can be a valuable tool in clinicians' hands for treating heart failure patients, as far as existing medical inaccuracies have been addressed before integrating AI into these frameworks.

A comprehensive review on federated learning based models for healthcare applications

A disease is an abnormal condition that negatively impacts the functioning of the human body. Pathology determines the causes behind the disease and identifies its development mechanism and functional consequences. Each disease has different identification methods, including X-ray scans for pneumonia, covid-19, and lung cancer, whereas biopsy and CT-scan can identify the presence of skin cancer and Alzheimer's disease, respectively. Early disease detection leads to effective treatment and avoids abiding complications. Deep learning has provided a vast number of applications in medical sectors resulting in accurate and reliable early disease predictions. These models are utilized in the healthcare industry to provide supplementary assistance to doctors in identifying the presence of diseases. Majorly, these models are trained through secondary data sources since healthcare institutions refrain from sharing patients' private data to ensure confidentiality, which limits the effectiveness of deep learning models due to the requirement of extensive datasets for training to achieve optimal results. Federated learning deals with the data in such a way that it doesn't exploit the privacy of a patient's data. In this work, a wide variety of disease detection models trained through federated learning have been rigorously reviewed. This meta-analysis provides an in-depth review of the federated learning architectures, federated learning types, hyperparameters, dataset utilization details, aggregation techniques, performance measures, and augmentation methods applied in the existing models during the development phase. The review also highlights various open challenges associated with the disease detection models trained through federated learning for future research.